Since γδ T cells may use TRAIL to kill tumor cells, we investigated the role of TRAIL/TRAIL-R system with a focus of TRAIL-R4 on the sensitivity of tumor cells toward γδ T cell-induced cytotoxicity. Here, TNFRSF10D is linked to neoplasm.